Form 8-K Clovis Oncology, Inc. For: Feb 25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Clovis Oncology (CLVS) Misses Q4 EPS Views
February 25, 2016 4:15 PM ESTClovis Oncology (NASDAQ: CLVS) reported Q4 EPS of ($3.12), $0.68 worse than the analyst estimate of ($2.44).
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
... More
